πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7323616

Genetically altered mice deficient in functional caspase-9

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7321063

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314885

Pyrrole compounds useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7312227

Compositions useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309716

Benzimidazoles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7304061

Heterocyclic inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7304071

Protein kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288624

Inhibitors of interleukin-1Ξ² converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7279476

Pyrazole-derived kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7279469

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7276502

Thiazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7273885

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271181

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271179

Inhibitors of JAK protein kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7268136

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7259161

Compositions useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7256190

Thiazole compounds useful as inhibitors of protein kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7253187

Heterocyclic inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7250520

Processes for preparing pyrroles

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244735

Heterocyclic protein kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7241796

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7226920

Aminotriazole compounds useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7216041

Methods of using the structure coordinates of molecules comprising an IMPDH-like binding p

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208600

Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted